Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
106.00    -2.60 (-2.39%)
Bid:
109.60
Ask:
107.40
Spread: -2.20 (-2.007%)
Market Cap: £178.04m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

FRS 101 Notification

10 Feb 2016 07:00

RNS Number : 4117O
Synthomer PLC
10 February 2016
 

NOTIFICATION TO SHAREHOLDERS IN ACCORDANCE WITH FRS 101

Synthomer plc has today posted a letter to shareholders, the full text of which is set out below.

 

 

Dear Shareholder

 

NOTIFICATION TO SHAREHOLDERS IN ACCORDANCE WITH FRS 101

 

On 1 January 2015 a new UK GAAP reporting regime became effective and, as a result, Synthomer plc ("the Company"), the parent company of the Synthomer Group, is obliged to transition to a replacement accounting framework for its financial statements for the financial year ended 31 December 2015. Accordingly, consistent with UK listed company market practice, your Board has decided to adopt FRS 101 "Reduced Disclosure Framework" for its Company financial statements. In this connection it is possible to elect to take advantage of disclosure exemptions, however, the Company disclosures are expected to be the same as, or follow closely, those reported under previous UK GAAP. There is no change to the accounting framework for the Group's consolidated financial statements, which will continue to be prepared in accordance with International Financial Reporting Standards, as adopted in the European Union.

 

Whilst your Board's decision does not require shareholder approval we are required under the rules issued by the Financial Reporting Council to inform our shareholders about the adoption of FRS 101, and to provide a reasonable opportunity for our shareholders to object. You do not need to reply to this letter, but any shareholder or shareholders holding in aggregate 5% or more of the total allotted shares in Synthomer plc can object to the adoption of FRS 101, if they wish to do so, by writing to the Company Secretary at Synthomer plc, Central Road, Harlow, Essex, CM20 2BH before 26 February 2016.

 

The election will apply on an ongoing basis until such time as the Company notifies shareholders of any change to its chosen accounting framework for its financial statements.

 

Contact: Richard Atkinson, Company Secretary

Stephen Bennett, Chief Financial Officer

UK Switchboard: +44 (0)1279 436 211

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSFFLAFMSEIE
Date   Source Headline
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue
7th Sep 20237:00 amRNSHalf-year results
18th Jul 20237:00 amRNSPost-close trading update
12th Jul 20233:17 pmRNSAppointment of Non-Executive Director
28th Jun 202312:37 pmRNSDirector/PDMR Shareholding
28th Jun 202312:36 pmRNSDirector/PDMR Shareholding
22nd Jun 202310:20 amRNSDirector/PDMR Shareholding
16th May 20234:00 pmRNSResult of AGM
16th May 20237:00 amRNSAGM trading update
12th May 20231:08 pmRNSDirector/PDMR Shareholding
12th May 20231:06 pmRNSDirector/PDMR Shareholding
13th Apr 202310:02 amRNSHolding(s) in Company
12th Apr 20235:52 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSRefinancing
28th Feb 20233:33 pmRNSDisposal
31st Jan 20237:00 amRNSPost-close update for the year ended 31 Dec 2022
11th Jan 202311:30 amRNSResult of General Meeting
16th Dec 202212:12 pmRNSPublication of Circular &Notice of General Meeting
13th Dec 20227:00 amRNSProposed Sale of Laminates, Films & Coated Fabrics
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSBoard changes
29th Nov 202211:16 amRNSOutcome of European Commission investigation
1st Nov 20222:53 pmRNSHolding(s) in Company
27th Oct 202210:27 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSCovenant relaxation to the end of 2023 agreed
13th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSInvestor Seminar
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 202210:40 amRNSDirector/PDMR Shareholding
4th Oct 202210:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.